Rockville, MD (PRWEB) August 08, 2013 Personalized Medicine and Companion Diagnostic Market Q2 2013 - A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment The personalized medicine and associated companion diagnostic market have huge opportunities for growth. This industry will revolutionize the healthcare system and will improve therapeutic effectiveness and reduce the severity of adverse effects. It has enormous potential for investment and the emergence of genetic-based in vitro diagnostics. Individualized, targeted or personalized medicine aims to increase the efficacy of therapeutics via genetic testing and companion diagnostics. Personalized therapeutics and associated companion diagnostics will be more specific and effective thereby giving pharma/biotech companies a significant advantage to recuperate R&D costs. Personalized medicine will reduce the frequency of adverse drug reactions and therefore have a dramatic impact on health economics. Developmental and diagnostic companies will benefit from lower discovery and commercialization costs and more specific market subtypes. This report describes the current technologies that are propelling the personalized medicine and companion diagnostic market. It examines the current genetic diagnostic tests and companion diagnostic assays that are in use by the medical and pharmaceutical industry today. Current developments in personalized medicine and the pharmacogenomics revolution are discussed. The emerging trends … Continue reading →

Doctors removed tissue from Henrietta Lacks' cervix In 1951. Those samples sparked decades of scientific discovery. STORY HIGHLIGHTS (CNN) -- In 1951, a doctor at Johns Hopkins Hospital removed two thin slivers of tissue from a dying woman's cervix. Cells from that biopsy would later multiply wildly and continuously -- a feat never seen until that time -- and become the cornerstone of research for diseases ranging from polio to Parkinson's disease. The woman's name was Henrietta Lacks. The cells, culled from her cancerous cervical tumor, are called HeLa. "Her cells were part of research into the genes that cause cancer and those that suppress it; they helped develop drugs for treating herpes, leukemia, influenza, hemophilia, and Parkinson's disease," wrote Rebecca Skloot in her book, "The Immortal Life of Henrietta Lacks." "They helped with some of the most important advances in medicine: the polio vaccine, chemotherapy, cloning, gene mapping, in vitro fertilization." HeLa cells are arguably one of the most important contributions to medicine ever made. And they're still the most commonly used cells in research today, Skloot told CNN. But although the cells have been a boon for the scientific community, they have been a persistent source of pain … Continue reading →

Adult Stem Cell Therapy for Back Pain A registered nurse describes her experience with an adult stem cell therapy procedure for back pain. More information at medrebels.org. By: medrebels1 … Continue reading →

Advanced Topics - Stem Cell Therapy part 2 By: Jesse Matteson … Continue reading →

Whoifwhat: Stem Cell Therapy- Knees, Hip, Back, etc.! It works: Now in St. Louis, New York Phily: coming to your town soon ! Using stem cells from belly fat ( got any) platelets to mark area an injection is ... By: whoifwhat … Continue reading →

Durham, NC (PRWEB) August 07, 2013 A new type of treatment that pairs neural stem cells with conventional cancer fighting therapies is showing promise in animal studies for the most common and deadliest form of adult brain cancer glioblastoma multiforme (GBM). The details are revealed in a groundbreaking study led by Maciej Lesniak, M.D., that appears today in STEM CELLS Translational Medicine. In this work, we describe a highly innovative gene therapy approach, which is being developed along with the NIH and the FDA. Specifically, our group has developed an allogeneic neural stem cell line that is a carrier for a virus that can selectively infect and break down cancer cells, explained Dr. Lesniak, the University of Chicagos director of neurosurgical oncology and neuro-oncology research at the Brain Tumor Center. The stem cell line, called HB1.F3 NSC, was recently approved by the FDA for use in a phase I human clinical trial. GBM remains fatal despite intensive treatment with surgery, radiation and chemotherapy. And while cancer-killing viruses have been used in clinical trials to treat therapeutically resistant and infiltrative tumor burdens throughout the brain, there were major drawbacks, Dr. Lesniak explained. When you inject a virus into a tumor alone … Continue reading →

Poway, California (PRWEB) August 06, 2013 The worlds leading Regenerative Veterinary Medicine company out of San Diego California, Vet-Stem, Inc., has entered into an exclusive partnership with The Veterinary Cooperative (TVC) that will allow over 300 member hospitals to immediately start offering Vet-Stems stem cell therapy and other Regenerative Veterinary Medicine services. Vet-Stems services have been used to treat over 10,000 animals in the last 10 years ranging from horses and dogs, to exotic cats and dolphins. Veterinarians using Vet-Stem cell therapy treat and conduct studies on traumatic and degenerative diseases, including bowed tendons, ligament injuries, osteoarthritis, and osteochondral defects. We are incredibly excited and appreciative to have become a long term exclusive provider to one of the countrys premier veterinary cooperatives. TVC is an excellent organization with tremendous leadership and members. Together we will help implement, train and grow the regenerative medicine business in each of the Hospitals associated with TVC. We very much admire the vision of TVC and all of its members in engaging in the future of regenerative medicine as true advanced medicine, Robert Harman, DVM, CEO of Vet-Stem, Inc. After carefully reviewing all regenerative medicine possibilities over the last year we have proudly chosen to … Continue reading →